Evangelos Terpos

2001–2025 年に発表

327
論文数
43,041
被引用数
106
h 指数
303
i10 指数

被引用数

Evangelos Terpos の年別被引用数1988 年: 被引用 1 件1990 年: 被引用 1 件2001 年: 被引用 1 件2002 年: 被引用 1 件2003 年: 被引用 15 件2004 年: 被引用 26 件2005 年: 被引用 31 件2006 年: 被引用 51 件2007 年: 被引用 92 件2008 年: 被引用 140 件2009 年: 被引用 166 件2010 年: 被引用 175 件2011 年: 被引用 172 件2012 年: 被引用 131 件2013 年: 被引用 155 件2014 年: 被引用 198 件2015 年: 被引用 196 件2016 年: 被引用 211 件2017 年: 被引用 244 件2018 年: 被引用 241 件2019 年: 被引用 1,002 件2020 年: 被引用 1,537 件2021 年: 被引用 1,961 件2022 年: 被引用 1,554 件2023 年: 被引用 935 件2024 年: 被引用 1,636 件2025 年: 被引用 714 件2026 年: 被引用 28 件1989 年は被引用が無いため表示していません1991〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,058 件、この内訳の 20.8%中国: 引用元論文 1,054 件、この内訳の 7.2%イタリア: 引用元論文 1,032 件、この内訳の 7%イギリス: 引用元論文 898 件、この内訳の 6.1%ドイツ: 引用元論文 841 件、この内訳の 5.7%フランス: 引用元論文 696 件、この内訳の 4.8%スペイン: 引用元論文 656 件、この内訳の 4.5%ギリシャ: 引用元論文 595 件、この内訳の 4.1%カナダ: 引用元論文 454 件、この内訳の 3.1%オランダ: 引用元論文 394 件、この内訳の 2.7%オーストラリア: 引用元論文 370 件、この内訳の 2.5%ベルギー: 引用元論文 313 件、この内訳の 2.1%
0%20.8%その他 29.4%

分野

  • Medicine80.4%
  • Biochemistry, Genetics and Molecular Biology13.1%
  • Immunology and Microbiology2.7%
  • Computer Science0.7%
  • Engineering0.7%
  • Materials Science0.4%
  • その他2%

トピック

  • Multiple Myeloma Research and Treatments12.9%
  • Protein Degradation and Inhibitors4.7%
  • COVID-19 Clinical Research Studies4.2%
  • Bone health and treatments3.6%
  • Peptidase Inhibition and Analysis3%
  • SARS-CoV-2 and COVID-19 Research2.8%
  • その他68.8%

共著者

全論文

検索で開く
  1. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wen-Ming Chen, Michèle Cavo, Jean‐Luc Harousseau, Suzanne Lentzsch, Jens Hillengaß, Antonio Palumbo, Alberto Órfão, S. Vincent Rajkumar, Jesús F. San Miguel, Hervé Avet‐Loiseau - The Lancet Oncology 2016 被引用: 2,995

  2. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Kyle, Kenneth C. Anderson, Brian G.M. Durie, Jesús F. San Miguel - The Lancet Oncology 2014 被引用: 4,869

  3. Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up.

    著者: , , , , , , , , , , , , , , , , - Annals of Oncology 2021 被引用: 820

  4. Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2023 被引用: 178

  5. Bone health in cancer: ESMO Clinical Practice Guidelines

    著者: , , , , , , , , , , , , - Annals of Oncology 2020 被引用: 518

  6. Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jelena Bila, Mario Boccadoro, Michèle Cavo, Javier de la Rubia Comos, Sosana Delimpasi, Meletios Α. Dimopoulos, Chantal Doyen, Dominik Dytfeld, Monika Engelhardt, Thierry Façon, Roberto Foà, Hartmut Goldschmidt, Sebastian Grosicki, Roman Hájek, Güner Hayri Özsan, Cyrille Hulin, Brian Iversen, Lionel Karlin, Eirini Katodritou, Stefan Knop, Marie‐Christine Kyrtsonis, Juan José Lahuerta, Xavier Leleu, Carmen Martínez Chamorro, María-Victoria Mateos Manteca, Nathalie Meuleman, Monique C. Minnema, Philippe Moreau, Massino Offidani, Albert Oriol Rocafiguera, Mustafa Pehlıvan, Luděk Pour, Henk Roerdink, Laura Rosinol Dacsh, Hans Salwender, Pieter Sonneveld, Anargyros Symeonidis, Charlotte Toftmann Hansen, Tülin Tuğlular, Ali Ünal, Philip Vlummens, Filiz Vural, Ka Lung Wu, Sonja Zweegman - The Lancet Oncology 2021 被引用: 327

  7. Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis

    著者: , , , , , , , , - Trends in Molecular Medicine 2022 被引用: 274

  8. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Baldeep Wirk, Matthew T. Drake, Michèle Cavo, Juan José Lahuerta, Suzanne Lentzsch - The Lancet Oncology 2019 被引用: 496

  9. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jesús F. San Miguel, Kenneth C. Anderson, Edward A. Stadtmauer, Rao Prabhala, Phillip McCarthy, Nikhil C. Munshi - The Lancet Haematology 2022 被引用: 191

  10. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2015 被引用: 762

  11. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katja Weisel, Rachid Baz, Vânia Hungria, Jesús G. Berdeja, Fernando Leal da Costa, Ângelo Maiolino, Anders Waage, David H. Vesole, Enrique M. Ocio, Hang Quach, Christoph Driessen, Joan Bladé, Xavier Leleu, Eloísa Riva, P. Leif Bergsagel, Jian Hou, Wee Joo Chng, Ulf‐Henrik Mellqvist, Dominik Dytfeld, Jean‐Luc Harousseau, Hartmut Goldschmidt, Jacob P. Laubach, Nikhil C. Munshi, Francesca Gay, Meral Beksaç, Luciano J. Costa, Martin Kaiser, Parameswaran Hari, Mario Boccadoro, Saad Z. Usmani, Sonja Zweegman, Sarah A. Holstein, Orhan Sezer, Simon J. Harrison, Hareth Nahi, Gordon Cook, María‐Victoria Mateos, S. Vincent Rajkumar, Meletios Α. Dimopoulos, Paul G. Richardson - The Lancet Oncology 2021 被引用: 268

  12. Multiple myeloma

    著者: , , , , , , , - Nature Reviews Disease Primers 2024 被引用: 257

  13. Pathogenesis of bone disease in multiple myeloma: from bench to bedside

    著者: , , , - Blood Cancer Journal 2018 被引用: 343

  14. Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients

    著者: , , , , , , , , , , , , , , - Cell Reports 2021 被引用: 237

  15. Hematological findings and complications of COVID‐19

    著者: , , , , , , , , - American Journal of Hematology 2020 被引用: 1,733

  16. Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 被引用: 520

  17. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study

    著者: , , , , , , , , , , , , - The Lancet Oncology 2018 被引用: 441

  18. Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker

    著者: , , , , , , , , , , , , , , , , - Cells 2022 被引用: 86

  19. Organ-specific manifestations of COVID-19 infection

    著者: , , , , , , , - Clinical and Experimental Medicine 2020 被引用: 519

  20. Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2023 被引用: 121

  21. Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group

    著者: , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2021 被引用: 197

  22. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashraf Badros, Philippe Moreau, K Kim, P R Otero, J H Lee, Chaim Shustik, Daniel D. Waller, Wee Joo Chng, Shuji Ozaki, J-J Lee, Javier de la Rubia, Hyeon‐Seok Eom, Laura Rosiñol, Juan José Lahuerta, Anna Sureda, Jin Seok Kim, B G M Durie - Leukemia 2017 被引用: 354

  23. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications

    著者: , , , , , , , , - Journal of Biomedical Science 2021 被引用: 283

  24. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 419